How do I install the Es Check Bmd Indication skill?

Run npx skillmds@latest add dromlakhani/es-check-bmd-indication in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Es Check Bmd Indication safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Es Check Bmd Indication?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Es Check Bmd Indication free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Es Check Bmd Indication?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Es Check Bmd Indication by dromlakhani

Name: Es Check Bmd Indication
Rating: 4.2 (5 reviews)
Author: dromlakhani

Es Check Bmd Indication

Determines whether bone mineral density (BMD) measurement is indicated when patients have osteoporosis risk factors or have discontinued sex hormone therapy following gonadectomy. Clinical triggers include documented osteoporosis risk factors (e.g., low body weight, glucocorticoid use, prior fracture) or cessation of sex hormone therapy after surgical gonadectomy.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Check if bone mineral density measurement is indicated

STEP 1 — Gather Information

Collect patient history: presence of osteoporosis risk factors (low body weight <60 kg, prior fragility fracture, chronic glucocorticoid use, hypogonadism, malabsorption, smoking, alcohol excess, family history of osteoporosis) and whether sex hormone therapy has been stopped after gonadectomy (orchiectomy, oophorectomy).

STEP 2 — Rule In / Rule Out

If any osteoporosis risk factor is present OR sex hormone therapy has been discontinued after gonadectomy → proceed to Step 3; otherwise → BMD measurement not indicated.

STEP 3 — Classify or Stratify

Classify as BMD indicated (no further stratification needed per guideline).

STEP 4 — Decide

Order dual-energy X-ray absorptiometry (DXA) scan of lumbar spine and hip; repeat monitoring per clinical judgment or as per Table 7/9 in guideline (every 1–2 years if indicated).

Clinical Guardrails / Mimics / Pitfalls

Do not order BMD solely based on transgender status without risk factors; interpret BMD using reference ranges for sex assigned at birth pending further data; avoid delaying BMD in patients on long-term hormone therapy who develop risk factors; ensure gonadectomy status is confirmed (surgical removal of gonads) before attributing indication to hormone cessation.

Concrete Clinical Example

A 28-year-old transgender female underwent orchiectomy and stopped estrogen therapy 6 months ago; she has a BMI of 18 kg/m2 and reports a prior wrist fracture. Risk factors present → BMD DXA ordered shows T-score -2.1 at lumbar spine, leading to initiation of osteoporosis treatment.

Source: Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons, Endocrine Society, 2017, DOI:10.1210/jc.2017-01658

---name: es-check-bmd-indicationdescription: Determines whether bone mineral density (BMD) measurement is indicated when patients have osteoporosis risk factors or have discontinued sex hormone therapy following gonadectomy. Clinical triggers include documented osteoporosis risk factors (e.g., low body weight, glucocorticoid use, prior fracture) or cessation of sex hormone therapy after surgical gonadectomy.---# Check if bone mineral density measurement is indicated## STEP 1 — Gather InformationCollect patient history: presence of osteoporosis risk factors (low body weight <60 kg, prior fragility fracture, chronic glucocorticoid use, hypogonadism, malabsorption, smoking, alcohol excess, family history of osteoporosis) and whether sex hormone therapy has been stopped after gonadectomy (orchiectomy, oophorectomy).## STEP 2 — Rule In / Rule OutIf any osteoporosis risk factor is present OR sex hormone therapy has been discontinued after gonadectomy → proceed to Step 3; otherwise → BMD measurement not indicated.## STEP 3 — Classify or StratifyClassify as BMD indicated (no further stratification needed per guideline).## STEP 4 — DecideOrder dual-energy X-ray absorptiometry (DXA) scan of lumbar spine and hip; repeat monitoring per clinical judgment or as per Table 7/9 in guideline (every 1–2 years if indicated).## Clinical Guardrails / Mimics / PitfallsDo not order BMD solely based on transgender status without risk factors; interpret BMD using reference ranges for sex assigned at birth pending further data; avoid delaying BMD in patients on long-term hormone therapy who develop risk factors; ensure gonadectomy status is confirmed (surgical removal of gonads) before attributing indication to hormone cessation.## Concrete Clinical ExampleA 28-year-old transgender female underwent orchiectomy and stopped estrogen therapy 6 months ago; she has a BMI of 18 kg/m2 and reports a prior wrist fracture. Risk factors present → BMD DXA ordered shows T-score -2.1 at lumbar spine, leading to initiation of osteoporosis treatment.**Source:** Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons, Endocrine Society, 2017, DOI:10.1210/jc.2017-01658

Frequently asked questions